Page 6 of 19 · 454 questions tagged vendor-vetting.
What I have: TFC · tirzepatide. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident several times…
Setup, so nobody has to ask: Medutest · Nantong Guangyuan Chemical. I would like help reading this properly rather than being told what conclusion to reach. I have…
The case in front of me: HJ · tirzepatide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Can…
Concretely: KP · retatrutide. I have a result I cannot explain, and I would rather diagnose it than guess. I have checked the obvious explanations and eliminated the…
This is my second independent submission on material from the same supplier. I have read the obvious sources and they disagree with each other, so I would rather ask…
Conditions: TFC · oral semaglutide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know whether this is…
Details up front: 99.1% · orforglipron · QYB. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which…
What I am working with: 96.8% · cagrilintide · QST. I am trying to build something sustainable rather than something thorough that I will abandon. I have already…
For reference: GL Biochem · ecnoglutide. Something has gone wrong and I would like to know how badly before I decide what to do. Nothing else in the setup changed,…
Stated plainly: QYB · Hubei Jianxiang Bioscience. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each…
Setup, so nobody has to ask: Homopeptide · oral semaglutide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone…
What I have: Homopeptide · tirzepatide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Is…
What I have: sampling plan · WXT. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
The case in front of me: QSC · cagrilintide. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources all citing…
I have kept every message, invoice and document, which I gather is the useful habit. I can find plenty of assertions about this and almost no reasoning, which is…
Following on from the certification discussion: I want to quantify the damage. Suppose a lab's standard is assigned 95.0% and its true potency is 88.0%. Does my…
Setup, so nobody has to ask: FGP · Xi’an Mokemei Biotechnology. Both of these get recommended confidently by different people, which suggests neither is obviously…
Stated plainly: VendorInvestigate · Shanghai Wibson Biotechnology. The figures are clear enough; the question is what they mean and what they do not. I can supply the…
This is my second independent submission on material from the same supplier. I can parse the result. I am less sure what it licenses me to conclude. I have…
The particulars: batch certificate · FGP. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
Setup, so nobody has to ask: FGP · a GLP-1 receptor agonist. This is asserted often enough that I assumed it was established, and then I went looking for the source.…
What I have: JEEP · Flourishglobal Peptide Biotech. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
This is my second independent submission on material from the same supplier. I have the document in front of me and I can read the numbers. What I cannot do is…
The case in front of me: GGPeps · ecnoglutide. Something has gone wrong and I would like to know how badly before I decide what to do. Nothing else in the setup…